Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
作者信息
DeGroot L J
出版信息
JAMA. 1997 Sep 17;278(11):895; author reply 898-9. doi: 10.1001/jama.278.11.895b.
PMID:9302231
Abstract
摘要
相似文献
1
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
JAMA. 1997 Sep 17;278(11):895; author reply 898-9. doi: 10.1001/jama.278.11.895b.
2
Thyroid storm.甲状腺危象
JAMA. 1997 Apr 16;277(15):1238-43.
3
Research suppressed for seven years by drug company.制药公司隐瞒研究成果长达七年。
BMJ. 1997 Apr 19;314(7088):1145. doi: 10.1136/bmj.314.7088.1145.
4
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
JAMA. 1997 Sep 17;278(11):896-7; author reply 898-9. doi: 10.1001/jama.1997.03550110034021.
5
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
JAMA. 1997 Sep 17;278(11):896; author reply 898-9. doi: 10.1001/jama.278.11.896c.
6
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
JAMA. 1997 Sep 17;278(11):895-6; author reply 898-9. doi: 10.1001/jama.1997.03550110033018.
7
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
JAMA. 1997 Sep 17;278(11):897; author reply 898-900. doi: 10.1001/jama.278.11.897b.
8
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
JAMA. 1997 Sep 17;278(11):897-8; author reply 898-900. doi: 10.1001/jama.1997.03550110035025.
9
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
JAMA. 1997 Sep 17;278(11):897; author reply 898-9. doi: 10.1001/jama.278.11.897d.
10
Bioequivalence of levothyroxine preparations: issues of science, publication, and advertising.
JAMA. 1997 Sep 17;278(11):896; author reply 898-9. doi: 10.1001/jama.278.11.896b.
Zotero 插件